Financials
Financial year 2025
Revenue
€ 22.5 million
▲ 22% vs 2024
Profit
Healthy€ 914,787
▼ 66% vs 2024
Debts
Low€ 6.2 million
▲ 12% vs 2024
Guidant Europe from Machelen (Brab.), company number BE0453573780, closed financial year 2025 with a result of € 914,787 after tax. For that financial year Guidant Europe recorded revenue of € 22.5 million and equity of € 14.5 million. Compared with financial year 2024, the result moved from € 2.7 million to € 914,787. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
What happened at Guidant Europe?
What happened at Guidant Europe in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Woodworth EMILY stepped down as director. NBB
- R. Brown VANCE stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 914,787 (▼ 66% vs 2024). Source: NBB ↗
- Woodworth EMILY became a director. NBB
- R. Brown VANCE became a director. NBB
- New establishment in Machelen (Brab.). KBO
- Start of the company according to the CBE. KBO
In short
From € 734,020 profit in 2021 to € 914,787 profit in 2025.
Paid € 2.8 million in corporate taxes since 2021.
Best year ever: 2024, with € 2.7 million profit.
Pays suppliers within 107 days on average.
A new publication or filing at Guidant Europe? We notify you, reason included.
Follow Guidant EuropeNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Boston Scientific Group Limited (100%) and Boston Scientific International B.V. (0%).
Directors
According to the 2025 annual accounts
since 2024 · until 2030
since 2024 · until 2030
Shareholders
Boston Scientific Group Limited
100%
Boston Scientific International B.V.
0%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Lambroekstraat 5D
1831 Machelen (Brab.)
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
BOSTON SCIENTIFIC BENELUX same network
€ 76.6 million revenue · 2025
SOFINDEV V
€ -2.1 million gross margin · 2025
SMGX
FPI Partners
Sofindev VI Investments (Privak)
+11 more
Details
- Company number
- 0453.573.780
- VAT number
- BE 0453.573.780
- Registered office
- Lambroekstraat 5D, 1831 Machelen (Brab.)
- Names & denominations
- Guidant Europe
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 October 1994
- Peppol
- Active · Active since 24 Mar 2026
- Activities · NACE
Activiteiten van hoofdkantoren
Coördinatiecentra
Handelsbemiddeling in de groothandel in andere specifieke goederen